Feiyu Chen
Lika, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
3D, multi-omic imaging reveals molecular biomarkers of the pre-metastatic niche in lung cancer.
Journal: bioRxiv : the preprint server for biology
Published: February 27, 2026
Suppression of lncRNA MALAT1 by betulinic acid inhibits hepatocellular carcinoma progression by targeting IAPs via miR-22-3p.
Journal: Clinical and translational medicine
Published: June 30, 2020
The Significance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma: Real-Time Monitoring and Moving Targets for Cancer Therapy.
Journal: Cancers
Published: May 28, 2020
ID1 overexpression increases gefitinib sensitivity in non-small cell lung cancer by activating RIP3/MLKL-dependent necroptosis.
Journal: Cancer letters
Published: October 07, 2019
Direct inhibition of the TLR4/MyD88 pathway by geniposide suppresses HIF-1α-independent VEGF expression and angiogenesis in hepatocellular carcinoma.
Journal: British journal of pharmacology
Published: September 06, 2019
Integrating Network Pharmacology and Pharmacological Evaluation for Deciphering the Action Mechanism of Herbal Formula Zuojin Pill in Suppressing Hepatocellular Carcinoma.
Journal: Frontiers in pharmacology
Published: April 18, 2019
The functional roles of exosomes-derived long non-coding RNA in human cancer.
Journal: Cancer biology & therapy
Published: February 12, 2019
microRNA-23a in Human Cancer: Its Roles, Mechanisms and Therapeutic Relevance.
Journal: Cancers
Published: November 26, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026